Skip to main content
. 2020 Apr 9;12(7):6436–6455. doi: 10.18632/aging.103041
Nova2 oligo forward: 5’-CTAGAGGAACCGGCGGGTCACCATCATTCAAGAGATGATGGTGACCCG CCGGTTCCTTTTTTG -3’
Nova2 oligo reverse: 5’-GATCCAAAAAAGGAACCGGCGGGTCACCATCATCTCTTGAATGATGGT GACCCGCCGGTTCCT-3’
Dcc oligo forward: CTAGAGCCATGACAGTCAATGGTACTTTCAAGAGAAGTACCATTGACT GTCATGGCTTTTTTG -3’
Dcc oligo reverse: 5’-GATCCAAAAAAGCCATGACAGTCAATGGTACTTCTCTTGAAAGTACCA TTGACTGTCATGGCT -3’
Netrin-1 oligo forward: 5’-CTAGAGGAAGTTCACCGTGAACATCATTCAAGAGATGATGTTCACGGT GAACTTCCTTTTTTG-3’
Netrin-1 oligo reverse: 5’-GATCCAAAAAAGGAAGTTCACCGTGAACATCATCTCTTGAATGATGTTC ACGGTGAACTTCCT-3’
Scrambled shRNA oligo forward: 5’-gatctGTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAG AATTTTTTc-3’
Scrambled shRNA oligo reverse: 5’-aattgAAAAAATTCTCCGAACGTGTCACGTTCTCTTGAAACGTGACACGTT CGGAGAACa-3’